Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities

Ludwig, 1980, Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease, Mayo Clin Proc, 55, 434

Powell, 1990, The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years, Hepatology, 11, 74, 10.1002/hep.1840110114

Ludwig, 1997, Review: nonalcoholic steatohepatitis, J Gastroenterol Hepatol, 12, 398, 10.1111/j.1440-1746.1997.tb00450.x

Brunt, 2000, Nonalcoholic steatohepatitis: a proposal for grading and staging the histologic lesions, Am J Gastroenterol, 94, 2467, 10.1111/j.1572-0241.1999.01377.x

Baker, 1985, Nonalcoholic steatonecrosis: a unique histopathologic lesion of the liver with multiple causes, Surv Dig Dis, 3, 154, 10.1159/000171122

Rozental, 1967, Liver morphology and function tests in obesity and during total starvation, Am J Dig Dis, 12, 198, 10.1007/BF02233443

Itoh, 1979, Five patients with nonalcoholic diabetic cirrhosis, Acta Hepatogastroenterol Stuttg, 26, 90

Bacon, 1994, Nonalcoholic steatohepatitis: an expanded clinical entity, Gastroenterology, 107, 1103, 10.1016/0016-5085(94)90235-6

Teli, 1995, The natural history of nonalcoholic fatty liver: a follow-up study, Hepatology, 22, 1714, 10.1002/hep.1840220616

Abdelmalek, 1995, Two cases from the spectrum of nonalcoholic steatohepatitis, J Clin Gastroenterol, 20, 127, 10.1097/00004836-199503000-00011

Sheth, 1997, Nonalcoholic steatohepatitis, Ann Intern Med, 126, 137, 10.7326/0003-4819-126-2-199701150-00008

Reaven, 1999, Syndrome X: 10 years after, Drugs, 58, 19, 10.2165/00003495-199958001-00006

Chen, 1999, The association of cardiovascular risk factor clustering related to insulin resistance syndrome (syndrome X) between young parents and their offspring: the Bogalusa Heart Study, Atherosclerosis, 145, 197, 10.1016/S0021-9150(99)00025-8

DeFronzo, 1991, Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease, Diabetes Care, 14, 173, 10.2337/diacare.14.3.173

Kawasaki, 1997, The relationship between fatty liver and hyperinsulinemia in obese Japanese children, J Pediatr Gastroenterol Nutr, 24, 317, 10.1097/00005176-199703000-00015

Lee, 1998, Role of hyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight, Korean J Intern Med, 13, 12, 10.3904/kjim.1998.13.1.10

Goto, 1995, The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects, Int J Obes Rel Metab Disord, 19, 841

Marchesini, 1999, Association of non-alcoholic fatty liver disease with insulin resistance, Am J Med, 107, 450, 10.1016/S0002-9343(99)00271-5

Ikai, 1995, Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people, J Hum Hypertens, 9, 101

Petrides, 1989, Glucose and insulin metabolism in cirrhosis, J Hepatol, 8, 107, 10.1016/0168-8278(89)90169-4

Petrides, 1994, Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis, Hepatology, 19, 616, 10.1002/hep.1840190312

The expert committee on the diagnosis and classification of diabetes mellitus, 1999, Report of the expert committee on the diagnosis and classification of diabetes mellitus, Diabetes Care, 22, s5

DeFronzo, 1979, The glucose clamp technique: a method for the quantitation of beta cell sensitivity to glucose and of tissue sensitivity to insulin, Am J Physiol, 237, E214

DeFronzo, 1985, Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin dependent (type II) diabetes mellitus, J Clin Invest, 76, 149, 10.1172/JCI111938

Frayn, 1983, Calculation of substrate oxidation rates in vivo from gaseous exchange, J Appl Physiol, 55, 628, 10.1152/jappl.1983.55.2.628

Zenger-hain, 1992, Diagnosis of inborn errors of phytanic acid oxidation using tritiated phytanic acid, 399

Lowry, 1951, Protein measurement with the Folin phenol reagent, J Biol Chem, 193, 265, 10.1016/S0021-9258(19)52451-6

Folch, 1957, A simple method for isolation and purification of total lipids from animal tissues, J Biol Chem, 226, 497, 10.1016/S0021-9258(18)64849-5

Beckman, 1993, Pathologic implications of NO, superoxide, and peroxynitrite formation, Biochem Soc Trans, 21, 330, 10.1042/bst0210330

Fritz, 1995, Quantitation in immunohistochemistry: a reserach method or a diagnostic tool in surgical pathology?, Pathologica, 87, 300

Wattanapitayakul, 2000, Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders, FASEB J, 14, 271, 10.1096/fasebj.14.2.271

Dustan, 1990, Obesity and hypertension in blacks, Cardiovasc Drugs Ther, 4, 395, 10.1007/BF02603183

Soares, 1979, Intramitochondrial paracrystalline inclusions in human hepatocytes, Am J Clin Pathol, 71, 479, 10.1093/ajcp/71.4.479

Rassat, 1981, Structural relationship between desmosomes and mitochondria in human livers exhibiting a wide range of diseases, Am J Pathol, 105, 207

Caldwell, 1999, Mitochondrial abnormalities in non-alcoholic steatohepatitis, J Hepatol, 31, 430, 10.1016/S0168-8278(99)80033-6

Shapiro, 1980, Hepatocyte mitochondrial alterations in griseofulvin fed mice, Ann Clin Lab Sci, 10, 45

Verheyen, 1976, Effects of levamisole on the ultrastructure of mitochondria in the liver of Beagle dogs, Vet Pathol, 13, 131, 10.1177/030098587601300207

Chen, 1992, Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection, Pathology, 24, 109, 10.3109/00313029209063634

Randle, 1963, The glucosefatty acid cycle: its role in insulin sensitivity and the metabolic disturbances in diabetes mellitus, Lancet, 1, 785, 10.1016/S0140-6736(63)91500-9

Ferrannini, 1983, Effects of free fatty acids on glucose production and utilization in man, J Clin Invest, 72, 1737, 10.1172/JCI111133

Bonadonna, 1994, Free fatty acid and glucose metabolism in human aging: evidence for operation of the Randle cycle, Am J Physiol, 266, E501

Zeviani, 1998, Mitochondrial disorders, Medicine, 77, 59, 10.1097/00005792-199801000-00006

Carafoli, 1986, Mitochondrial pathology: an overview, Ann N Y Acad Sci, 488, 1, 10.1111/j.1749-6632.1986.tb46544.x

Lombes, 1989, Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuropathology, biochemistry, and molecular genetics, Ann Neurol, 26, 20, 10.1002/ana.410260104

Larsson, 1995, Molecular genetic aspects of human mitochondrial disorders, Annu Rev Genet, 29, 151, 10.1146/annurev.ge.29.120195.001055

Weltman, 1998, Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis, Hepatology, 27, 128, 10.1002/hep.510270121

Nelson, 1998, Metazoan cytochrome P450 evolution, Comp Biochem Physiol C Pharmacol Toxicol Endocrinol, 121, 15, 10.1016/S0742-8413(98)10027-0